70518-4614-0 : NDC 2026 Code

70518-4614-0 : Dapagliflozin ( Farxiga )

Additionally :

You can get information about “70518-4614-0” NDC code in 70518-4614-0 in HTML format

HTML | 70518-4614-0 in TXT (Plain Text) format

TXT | 70518-4614-0 in PDF (Portable Document Format)

PDF | 70518-4614-0 in XML format

XML formats.

NDC Code : 70518-4614-0 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "70518-4614-0",
    "PackageDescription": "50 POUCH in 1 BOX (70518-4614-0)  / 1 TABLET, FILM COATED in 1 POUCH (70518-4614-1) ",
    "NDC11Code": "70518-4614-00",
    "ProductNDC": "70518-4614",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Farxiga",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Dapagliflozin",
    "DosageFormName": "TABLET, FILM COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20260423",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA202293",
    "LabelerName": "REMEDYREPACK INC.",
    "SubstanceName": "DAPAGLIFLOZIN PROPANEDIOL",
    "StrengthNumber": "5",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-04-28",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260423",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}